Companies: 10,795·Total market cap: $144.5T
Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd.

CMMBNASDAQHealthcare● Active
$1.82
+$0.05(+2.82%)
Market Cap$11202313
P/E Ratio—
52W High$5.48
52W Low$1.35
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Chemomab Therapeutics Ltd. (CMMB) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001534248 · CMMB · NASDAQ · as of Jun 8, 2026

Filing snapshot

350
Total Filings
3
Latest Form
2026-06-03
Most Recent
2019
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001534248 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-03-23
Fiscal Year End
Mar 23, 2026
Accession No.
0001178913-26-001593
Primary Document
zk2634510.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001534248 · Accession 0001178913-26-001593

Latest Key Filings

6-KQuarterly Report
6-K
2026-06-02
View 6-K on SEC
8-KCurrent Report
8-K
2023-06-16Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
3Initial Statement of Beneficial Ownership
FORM 3
2026-06-03
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-06-02
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-05-14
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-05-06
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-04-28
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-10
View
3Initial Statement of Beneficial Ownership
FORM 3
2026-04-10
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-10
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-10
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-10
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-10
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-31
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-31
View
20-FAnnual Report (Foreign Issuer)
20-F
2026-03-23
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-03-20
View
Showing 1–15 of 311 filingsForm 4 / 144 hidden· 350 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001534248  |  Exchange: NASDAQ · Healthcare

Chemomab Therapeutics Ltd. (NASDAQ: CMMB) has submitted 350 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2019. As a Healthcare sector company with CIK 0001534248, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Chemomab Therapeutics Ltd.'s most comprehensive regulatory disclosure. The most recent Chemomab Therapeutics Ltd. 10-K was filed on 2026-03-23 for fiscal year ending 2026. Historical CMMB 10-K annual reports are available from 2011 through 2026.

Investors researching Chemomab Therapeutics Ltd. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
KZIA SEC Filings →BIVI SEC Filings →TOVX SEC Filings →ELAB SEC Filings →GLMD SEC Filings →INM SEC Filings →CANF SEC Filings →XRTX SEC Filings →
→ CMMB Financials→ CMMB Earnings→ CMMB Insider Trades

Frequently Asked Questions

CMMB SEC Filings · 8 questions

Chemomab Therapeutics Ltd. (CMMB) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 350 filings and access original documents at no cost. Chemomab Therapeutics Ltd.'s CIK is 0001534248.

CMMB SEC filingsChemomab Therapeutics Ltd. SEC documentsfind CMMB 10-K